Edmund Ingham's Stock Coverage
| RVMDRevolution Medicines | Nov 05, 2026 | Neutral | 2Ratings | +62.60% | ||
| MDGLMadrigal Pharmaceuticals | Nov 04, 2026 | Bullish | 4Ratings | -0.10% | ||
| BCRXBioCryst | Nov 04, 2026 | Neutral | 3Ratings | -47.10% | ||
| GILDGilead Sciences | Oct 30, 2026 | Neutral | 7Ratings | +13.13% | ||
| ARDXArdelyx | Oct 30, 2026 | Neutral | 1Ratings | ― | ― | |
| AGIOAgios Pharma | Oct 30, 2026 | Bullish | 2Ratings | +20.60% | ||
| GERNGeron | Oct 29, 2026 | Neutral | 2Ratings | +115.00% | ||
| NOVONovo Nordisk A/S Shs Unsponsored Canadian Depository Receipt Hedged | Oct 27, 2026 | Bullish | 3Ratings | +6.75% | ||
| NVONovo Nordisk | Oct 27, 2026 | Bullish | 6Ratings | +0.50% | ||
| LLYEli Lilly & Co | Oct 27, 2026 | Bullish | 13Ratings | +35.17% |
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site. See how TipRanks ranks experts and calculates performance.